METHODS
We investigated the epigenetic basis of acquired drug resistance in whole genome by comparing chromosome
immunoprecipitation in paclitaxel-resistant MCF-7 (MCF-7/Pac) cells and in drug-sensitive
(MCF-7/S) cells. For this analysis, DNA samples from both cell lines were immunoprecipitated and
labeled with Cy3 and Cy5 fluorescent dyes. Hybridization and array scanning was performed with Agilent
all-Genome Microarray platform that was designed to detect DNA methylation. The obtained highthroughput
information was analyzed with a bioinformatics analysis program.
RESULTS
The results showed that demethylation and epigenetic modulation of the DNA regions encoding 90
genes are significant in the development of multiple drug resistance (MDR) in breast cancer. Some of
these genes, ICAM4, COX6B2, ITGB8, SLC39A4, TUBB2C, COL6A1, DAPK1, RUNX3, SLC35F3, and
MAP6, are important players in the development of drug resistance and cancer stem cells.
CONCLUSION
Studies on reversing multidrug resistance can be carried out by DNA modification or methylation of
target genes regions on DNA. The results presented in this study may shed light on drug development
studies to make DNA modifications.
Keywords: Demethylation; epigenetics; multidrug resistance; MDR; MCF-7; paclitaxel
The most emphasized mechanisms is the DNA
methylation, which is the hereditary change caused
by the addition of methyl group to the 5' end of the
cytosine followed by the guanine nucleotide by the
catalysis of enzyme DNA methyl transferase.[
Drug resistance, which is acquired or intrinsic in
the patient post-treatment or pre-treatment period, severely
prevents success in cancer chemotherapy. This
case is called multidrug resistance (MDR).[
This study aimed to determine the effects of DNA
demethylation and epigenetic bases of drug resistance
mechanisms developed in MCF-7 breast cancer
cell line that is resistant to anticancer agent paclitaxel
(MCF-7/Pac). The resistant cell line was developed by
treatment of MCF-7 breast cancer cells with paclitaxel
by dose increments. Paclitaxel is an anticancer drug
that inhibits cell division by interfering microtubules
during mitosis. Changes in gene expression profiles
of paclitaxel-resistant MCF-7 (MCF-7/Pac) cells compared
to drug-sensitive (MCF-7/S) cells have been presented
in previous publications.[
DNA Isolation and Immunoprecipitation
The experiments were conducted according to Agilent
G4170-90012_Methylation_Protocol_v.2.0 in the laboratories
of Selçuk University ILTEK. The genomic DNA
isolation from MCF-7/S and MCF-7/Pac cells (1×106
cells from each) was performed using the genomic
DNA isolation kit (QIAamp DNA mini kit, QIAGEN).
The quality control procedure was performed by spectrophotometric
measurements (OD260nm/OD280nm,
Nanodrop-Thermo) and agarose gel electrophoresis.
Genomic DNA (5 µg from each) was fragmented by
ultrasonication by ultrasonicator (using micro probe,
Heidolph) that was set output power to 70%. The DNA
fragmentation was ensured by sonicating the DNA
samples for 5 s, five cycles on ice by holding 5 s between
each cycle intervals (to prevent heating and foaming).
For immunoprecipitation procedure, Dynabeads Pan
Mouse IgG magnetic beads were precipitated by magnetic
stand (DynaMag-2 Magnet, Life Technologies),
and the beads were bound to ChIP grade anti-5-Methyl
Cytidine antibody (Abcam) by incubating in a rotator
(VWR) at 4°C incubator. The fragmented DNA samples
were then hybridized with the magnetic bead bound
5-methylcytidine antibody in immunoprecipitation
buffer (Triton X, yeast t-RNA, PBS) to let the binding
of methylated DNA fragments on to the magnetic antibodies
(in rotator, overnight at 4°C incubator). Finally,
the methylated DNA fragments were sorted on
magnetic stand. The methylated DNA samples and
reference DNA samples (that were not immunoprecipitated)
were eluted by elution in TE and SDS solution.
DNA fragments were extracted through phenol-chloroform
extraction method by use of MaXtract High
Density tubes (QIAGEN). The aqueous phase was collected,
and DNA was precipitated by adding the precipitation
solution that constitutes NaCl (200 mM), glycogen
20 ?g/mL, and pure ethanol. DNA was precipitated
by incubating the mixture at 4°C and centrifugation at
12.000 g for 3 min (Hettich). Finally, the DNA pellets
were air dried. The quality of eluted methylated DNA and reference DNA samples of MCF-7/Pac and MCF-
7/S were measured by Nanodrop (Thermo).
Fluorescent Labeling of DNA Samples
Methylated and reference DNA fragments were labeled
using the SureTag DNA Labeling Kit (Agilent). Briefly,
DNA samples were mixed with random primers and
incubated at 95°C for 3 min on heating-cooling dry
block (Biosan). While DNA samples were denatured,
they were labeled by Exo Klenow enzyme, dNTPs. and
fluorescently labeled dUTPs (Cy-3 and Cy-5 labeled) at
37°C for 2 h in PCR machine (Biorad). After the reaction
was stopped at 65°C, labeled DNA fragments were
purified by purification columns, and fluorescence
binding success was determined by spectrophotometric
measurements (Nanodrop, Thermo). Specific activity
and labeled DNA amounts were calculated using
the following formulas:
Specific activity=pmol dye per µL of dye/µg per µL DNA Yield (µg)=DNA concentration (ng/µL)×sample volume (µL)/1000 ng/?g
Hybridization of Labeled DNA on Arrays
Since DNA labeling quality was good (yield >2.5 µg and
appropriate specific activity), the labeled DNA fragments
were hybridized on the array platforms (Human
DNA Methylation Microarray, 1×244K (HD)). Briefly,
the hybridization master mix was prepared for four
samples (duplicates for each cell line). Hybridization
master mix constituted Human Cot-1 DNA for internal
control, CGH (chromosomal genomic hybridization)
blocking agent, HI-RPM hybridization buffer,
and deionized formamide. Hybridization master mix
(420 µL for 1-pack microarray format) was combined
with Cy3- and Cy5-labeled DNA samples (40 µL each)
in one tube for each cell line. Two replicates of hybridization
mixtures were prepared for MCF-7/S and
MCF-7/Pac cell lines and incubated at 95°C for 3 min
and 37°C for 30 min in thermal cycler (Biorad). The
hybridization solution should be kept at 37°C until it
is loaded on to the array slides. Hybridization solution
was slowly dispensed on to the gasket slide carefully
preventing the overflow of the solution out of the gasket
chamber. Then the printed microarray slide (Agilent,
Unrestricted Amadid Chip-on-Chip 1×244K) was
put on to the gasket slide (barcode number should be
outside). Finally, the microarray slide was assembled
in the slide chamber. The hybridization oven was set
to 67°C, and the chambers were placed in to the array
holders in a balanced way. The hybridization proceeded for 40 h at 20 rpm rotation speed. Two repeats
were performed for each group (MCF-7/S and MCF-7/
Pac), (n=2).
Washing and Scanning
The washing equipments were washed with acetonitrile
and ultrapure water previously. ChIP-on-chip wash buffer
2 was prewarmed in a coplin jar before disassembling
the slide chambers (37°C). The slides were disassembled
in ChIP-on-chip wash buffer 1, in to a separate coplin jar.
Then the slides were put into another jar that contains
wash buffer 1 for 5 min at room temperature (a magnetic
bead was put at the basement of the jar to provide
continuous stirring by magnetic stirrer). Arrays were
immediately air dried, and ozone covers were put on
to prevent adverse effects of the ozone on to the slides.
During the whole procedure, slides should be kept by
forceps. Sure Scan Microarray Scanner (Agilent), which
was in the laboratory of Selçuk University ILTEK, was
turned on to warm up the lasers. The G4900DA SureScan
Microarray Scanner System Microarray Scan Control
Software 9.1 (Agilent) was run, and Protocol Agilent
HD-CGH was selected. The slides were immediately inserted
into the scanner as the scanner was ready to scan
the arrays. The machine recognized the barcode of the
array. The green and red lasers excited the fluorescent
dyes, and then photomultiplier tube detector detected
the data. After scan protocol was completed, the Feature
Extraction software v11.0.1.1 was operated for quality
control (QC). The QC reports were generated using
the grid Human DNA Methylation Microarray 244k-
023795-D-F-20111018.
Advanced Analysis and Statistics
The scan data of each cells were analyzed by Genomic
Workbench ver6.0 (Agilent) program. Z-score algorithm
was used for calculations. Gaussians were fitted
to the bimodal log ratio distribution. Significant
changes were determined between the groups (MCF-
7/S and MCF-7/Pac) by Student"s t-test (p<0.05).
Finally, the significant results were listed, and the
demethylation levels were calculated by calculating the
fold change values and presented as the logarithm of
the fold change ratios (MCF-7/Pac/MCF-7).
Hybridization, Washing, and Scanning Protocols
The hybridization, washing, and scanning protocols
were completed; and the QC reports were created for
each arrays with the Feature Extraction program (Agilent).
The results obtained for all the scanning protocols
were reported as "good." The scan image and grid results
obtained after scanning are presented in Figure
Advanced Analysis by Genomic Workbench
Program
The raw data obtained after scanning the arrays were
analyzed by Genomic Workbench ver6.0 (Agilent).
The fluorescence values were analyzed, and array results
for MCF-7/S and MCF-7/Pac were compared. As
a result, when the drug resistance was developed, decreases
in the methylation level of the gene regions on
DNA (demethylation) were identified. The fold change
values were calculated to reveal the demethylation levels
after acquired drug resistance. The logarithms of the results were calculated and significant results were
listed (p<0.05) (Table
It was previously claimed that intercellular adhesion
protein-coding gene ICAM4 may be a breast cancer
susceptibility gene, and genetic variants in the DNA
loci was correlated with disease severity and metastasis.[
Acknowledgment: We acknowledge support from Selçuk University BAP.
Peer-review: Externally peer-reviewed.
Conflict of Interest: The authors have no conflict of interest
pertaining to this manuscript.
Ethics Committee Approval: Since cell lines were used in
this study, ethics committee permission is not required.
Financial Support: Selçuk University BAP project (number
14401033).
Authorship contributions: Concept ? M.D.K.; Design ? M.D.K.; Supervision ? M.D.K.; Materials ? G.K.; Data collection &/or processing ? G.K.; Analysis and/or interpretation ? G.K.; Literature search ? M.D.K.; Writing ? M.D.K.; Critical review ? M.D.K.